Multiple SEC complaints and shareholder lawsuits will change that very quickly. There are numerous other OTC tickers who have and are currently under investigations. If they are frauding investors, they will get charged. They PR BS, dilute, and repeat. No sales seem to have been made overseas or any products shipped like they told shareholders it would be done in March. Nothing about Nupelo or Dubai or all the 50 states licensing deals which were supposed to be done by the end of last year. They cannot hide behind their BS or from angry shareholders any longer.
News 
Market Data 
Discover 
AI
